Inhibition of telomerase is a novel and effective therapy in MLL-rearranged acute myeloid leukemia (AML) Meeting Abstract


Authors: Bruedigam, C.; Bagger, F. O.; Kuhn, C. P.; Vu, T.; Austin, R.; Heidel, F. H.; Bullinger, L.; Hill, G. R.; Armstrong, S. A.; Williams, D. A.; Lane, S. W.
Abstract Title: Inhibition of telomerase is a novel and effective therapy in MLL-rearranged acute myeloid leukemia (AML)
Meeting Title: 55th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 122
Issue: 21
Meeting Dates: 2013 Dec 7-10
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2013-11-15
Language: English
ACCESSION: WOS:000331385006158
PROVIDER: wos
DOI: 10.1182/blood.V122.21.2887.2887
Notes: Meeting Abstract: 2887 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Scott Allen Armstrong
    108 Armstrong